Clinical trials: Seborrheic Keratoses
Seborrheic Keratosis
Study of A-101 for the Treatment of Seborrheic Keratosis
The purpose of this study is to evaluate the safety and dose-response of 2 concentrations of A-101 versus a vehicle control in the treatment of seborrheic keratosis.
- Trial name
- NCT02260180
- Testing
- A-101
- Where
- 4 sites in United States
- Volunteers
- 119 people
- Sponsor
- Aclaris Therapeutics, Inc.
Seborrheic Keratosis
A Study of A-101 Solution 40% in Subjects With Seborrheic Keratosis.
This is a randomized, double-blind, vehicle-controlled, parallel group study of A-101 Solution 40% compared with Vehicle Solution.
- Trial name
- NCT02667236
- Testing
- A-101 Solution, Vehicle Solution
- Where
- United States
- Volunteers
- 450 people
- Sponsor
- Aclaris Therapeutics, Inc.
Seborrheic Keratosis
An Open-Label Safety Study of A-101 Solution
This is an open-label safety study. During this study, the investigator will identify 4 eligible SK Target Lesions on each subject on the trunk, extremities and face.
- Trial name
- NCT02667288
- Testing
- A-101 Solution
- Where
- United States
- Volunteers
- 147 people
- Sponsor
- Aclaris Therapeutics, Inc.
Seborrheic Keratosis
An A Study Assessing Subject Satisfaction With A-101 Topical Solution for Seborrheic Keratoses
This study is an open-label study designed to evaluate subject's satisfaction after treatment of seborrheic keratoses with A-101 40%.
- Trial name
- SK-FAN (NCT03487588)
- Testing
- A-101 Topical Solution
- Where
- 3 sites in United States
- Volunteers
- 41 people
- Sponsor
- Aclaris Therapeutics, Inc.
Seborrheic Keratosis
A Randomized, Double-Blind, Vehicle-Controlled Study in Subjects With Seborrheic Keratosis
This is a randomized, double-blind, vehicle-controlled, parallel group study.
- Trial name
- SK (NCT02667275)
- Testing
- A-101 Solution, Vehicle Solution
- Where
- United States
- Volunteers
- 487 people
- Sponsor
- Aclaris Therapeutics, Inc.
Seborrheic Keratosis (SK)
Study of Safety, Tolerability and Effectiveness of A-101 in Subjects With Seborrheic Keratosis
Evaluate the safety, tolerability of A-101 when applied to seborrheic keratosis lesions on the back of subjects.
- Trial name
- NCT01986920
- Testing
- A-101 25%, A-101 32.5%, A-101 40%
- Where
- United States
- Volunteers
- 35 people
- Sponsor
- Aclaris Therapeutics, Inc.
Facial Dermatoses, Seborrheic Keratoses
Dermatosis Papulosa Nigra
DPN is a disorder among darkly pigmented patients, manifested by small, benign, variants of seborrheic keratoses, predominantly on the face.
- Trial name
- DPN (NCT00710203)
- Testing
- Pulsed dye laser, Curettage, Electrodesiccation
- Where
- United States
- Volunteers
- 10 people
- Sponsor
- University of California, Davis
Seborrheic Keratosis
Dose-Response Profile of A-101 in Subjects With Seborrheic Keratosis
The main objective of this study is to evaluate the dose-response relationship of two concentrations of A-101 solution when applied to individual seborrheic keratosis (SK) lesions (target lesions) compared with a matching A-101…
- Trial name
- NCT02160626
- Testing
- A-101 Vehicle, A-101 (40) Topical Solution, A-101 (32.5) Topical Solution
- Where
- 5 sites in United States
- Volunteers
- 172 people
- Sponsor
- Aclaris Therapeutics, Inc.
Seborrheic Keratosis
A Randomized, Vehicle-Controlled Study of 2 Concentrations of A-101 for the Treatment of Seborrheic Keratosis
The primary objective of this study is to evaluate the safety and effectiveness of 2 concentrations of A-101 compared to Vehicle for the treatment of 4 seborrheic keratosis (SK) Target Lesions on the trunk, extremities and face.
- Trial name
- NCT03148691
- Testing
- A-101
- Where
- 9 sites in United States
- Volunteers
- 253 people
- Sponsor
- Aclaris Therapeutics, Inc.
Lesion Skin, Seborrheic Keratosis
Nano-Pulse Stimulation (NPS) in Seborrheic Keratosis Study
The primary purpose of this trial is to evaluate Nano-Pulse Stimulation (NPS) to clear or remove Seborrheic Keratosis (SK) lesions from off-facial areas of healthy adult subjects.
- Trial name
- NCT03846531
- Testing
- Nano-Pulse Stimulation (NPS)
- Where
- 4 sites in United States
- Volunteers
- 58 people, healthy volunteers welcome
- Sponsor
- Pulse Biosciences, Inc.